In this study, we aimed to investigate the anticancer efficacy of virus-mediated CRISPR/Cas9 gene therapy targeting the human ABL gene in CML cells in vitro and in vivo (Figure 8). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.